Insmed Current Liabilities vs Total Assets Analysis

INSM Stock  USD 28.06  0.34  1.23%   
Insmed financial indicator trend analysis is infinitely more than just investigating Insmed Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Insmed Inc is a good investment. Please check the relationship between Insmed Current Liabilities and its Total Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Current Liabilities vs Total Assets

Current Liabilities vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Insmed Inc Current Liabilities account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Insmed's Current Liabilities and Total Assets is 0.92. Overlapping area represents the amount of variation of Current Liabilities that can explain the historical movement of Total Assets in the same time period over historical financial statements of Insmed Inc, assuming nothing else is changed. The correlation between historical values of Insmed's Current Liabilities and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Liabilities of Insmed Inc are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Current Liabilities i.e., Insmed's Current Liabilities and Total Assets go up and down completely randomly.

Correlation Coefficient

0.92
Relationship DirectionPositive 
Relationship StrengthVery Strong

Current Liabilities

The current portion of Total Liabilities; reported if the company operates a classified balance sheet that segments current and non-current liabilities.

Total Assets

Total assets refers to the total amount of Insmed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Insmed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.
Most indicators from Insmed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Insmed Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
At this time, Insmed's Selling General and Administrative Expense is very stable as compared to the past year. As of the 2nd of March 2024, Net Cash Flow Business Acquisitions and Disposals is likely to grow to about 4.2 M, while Net Cash Flow Investment Acquisitions and Disposals is likely to drop (219.4 M).
 2021 2022 2023 2024 (projected)
Interest Expense40.5M26.4M81.7M88.1M
Gross Profit144.3M190.2M239.6M194.8M

Insmed fundamental ratios Correlations

0.950.930.950.920.950.830.870.440.870.870.980.530.49-0.490.880.90.870.860.910.91
0.950.920.950.930.960.820.930.490.930.850.960.620.58-0.590.930.940.930.90.920.95
0.930.920.930.920.90.820.910.550.910.80.940.620.58-0.590.920.950.910.890.840.89
0.950.950.930.990.940.930.910.520.910.880.930.540.49-0.480.920.920.910.880.880.9
0.920.930.920.990.90.950.90.540.90.840.90.50.45-0.440.90.910.90.840.870.87
0.950.960.90.940.90.770.940.420.940.940.970.680.65-0.660.950.950.950.950.850.96
0.830.820.820.930.950.770.740.540.740.720.760.220.17-0.170.740.760.740.670.80.69
0.870.930.910.910.90.940.740.421.00.870.930.790.75-0.761.00.981.00.970.790.96
0.440.490.550.520.540.420.540.420.420.250.440.250.25-0.250.430.530.420.340.610.43
0.870.930.910.910.90.940.741.00.420.870.930.790.75-0.761.00.981.00.970.790.96
0.870.850.80.880.840.940.720.870.250.870.890.630.59-0.580.880.840.880.930.670.87
0.980.960.940.930.90.970.760.930.440.930.890.70.66-0.660.940.950.940.940.880.97
0.530.620.620.540.50.680.220.790.250.790.630.70.99-0.980.790.780.790.820.470.8
0.490.580.580.490.450.650.170.750.250.750.590.660.99-0.990.750.750.750.790.440.77
-0.49-0.59-0.59-0.48-0.44-0.66-0.17-0.76-0.25-0.76-0.58-0.66-0.98-0.99-0.76-0.76-0.76-0.79-0.43-0.76
0.880.930.920.920.90.950.741.00.431.00.880.940.790.75-0.760.991.00.980.80.96
0.90.940.950.920.910.950.760.980.530.980.840.950.780.75-0.760.990.980.960.840.96
0.870.930.910.910.90.950.741.00.421.00.880.940.790.75-0.761.00.980.980.790.96
0.860.90.890.880.840.950.670.970.340.970.930.940.820.79-0.790.980.960.980.710.95
0.910.920.840.880.870.850.80.790.610.790.670.880.470.44-0.430.80.840.790.710.87
0.910.950.890.90.870.960.690.960.430.960.870.970.80.77-0.760.960.960.960.950.87
Click cells to compare fundamentals

Insmed Account Relationship Matchups

Insmed fundamental ratios Accounts

201920202021202220232024 (projected)
Inventories28.3M49.6M67.0M69.9M62.9M51.8M
Receivables19.2M16.6M24.4M29.7M26.7M28.9M
Accounts Payable13.2M42.9M35.8M50.5M45.4M49.0M
Accumulated Other Comprehensive Income(10K)193K968K756K(745K)(764.6K)
Total Assets742.3M796.2M1.2B1.7B1.3B1.1B
Current Assets555.2M622.9M837.0M1.3B929.1M797.6M
Assets Non Current187.1M173.3M406.5M383.1M400.8M432.4M
Cash and Equivalents487.4M532.8M716.8M1.1B482.4M511.2M
Cash and Equivalents USD487.4M532.8M716.8M1.1B482.4M511.2M
Total Debt397.0M404.8M612.3M1.3B1.4B1.5B
Debt Non Current384.8M392.3M602.1M1.3B1.3B1.5B
Total Debt USD397.0M404.8M612.3M1.3B1.4B1.5B
Shareholders Equity Attributable to Parent261.7M275.9M410.5M88.0M(331.9M)(340.7M)
Shareholders Equity USD261.7M275.9M410.5M88.0M(331.9M)(340.7M)
Goodwill and Intangible Assets53.7M49.3M209.9M204.9M199.8M174.2M
Inventory28.3M49.6M67.0M69.9M83.2M73.3M
Total Liabilities480.6M520.3M833.0M1.6B1.7B1.8B
Current Liabilities85.2M118.8M135.2M190.2M225.6M243.4M
Liabilities Non Current395.4M401.5M697.9M1.4B1.4B1.5B
Trade and Non Trade Payables13.2M42.9M125.0M182.1M215.0M232.0M
Property Plant and Equipment Net113.1M97.2M95.5M102.1M104.4M85.2M
Trade and Non Trade Receivables19.2M16.6M24.4M29.7M41.2M34.9M
Accumulated Retained Earnings Deficit(1.5B)(1.8B)(2.3B)(2.7B)(3.4B)(3.5B)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.34)
Revenue Per Share
2.173
Quarterly Revenue Growth
0.411
Return On Assets
(0.28)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.